|
Status |
Public on Jul 31, 2014 |
Title |
Patient 7 in group SynSa2 [transcriptome] |
Sample type |
RNA |
|
|
Source name |
tumor sample
|
Organism |
Homo sapiens |
Characteristics |
histosubtype: synovial sarcoma age at diagnosis [years]: 47 gender: Male
|
Treatment protocol |
not applicable
|
Growth protocol |
not applicable
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA of sufficient integrity and purity was obtained from 57 tumor specimens using the miRNeasy Mini Kit (Qiagen) with optional DNase treatment using RNase-free DNase Set (Qiagen). RNA quality was checked using Bio-Rad Experion system (Bio-Rad Laboratories).
|
Label |
Cy3
|
Label protocol |
Total RNA (25ng) was reverse transcribed into cDNA by incorporating a T7 oligo-dT promoter primer prior to the generation of fluorescent cRNA using an Agilent LowInput Quick Amp Labeling Kit (Agilent Technologies, SantaClara, CA, USA).
|
|
|
Hybridization protocol |
Gene expression analysis was performed using Human Gene Expression 4x44K v2 microarrays (G4845A) according to the one-color microarray-based expression analysis protocol (Agilent Technologies).
|
Scan protocol |
The microarray slides were scanned using the Agilent G2565A DNA Microarray Scanner (Agilent Technologies, SantaClara, CA, USA).
|
Description |
Gene expression in primary tumor sample
|
Data processing |
Image analysis was done using the Feature Extraction V10.10.1.1 software (Agilent Technologies, SantaClara, CA, USA). Microarray data were analyzed using Gene Spring GX default workflow parameters for Agilent one-color expression experiments (Agilent Technologies, SantaClara, CA, USA).
|
|
|
Submission date |
Jan 17, 2014 |
Last update date |
Jul 31, 2014 |
Contact name |
Joanna Przybyl |
E-mail(s) |
jprzybyl@stanford.edu
|
Organization name |
Stanford University
|
Department |
Department of Pathology
|
Street address |
300 Pasteur Drive
|
City |
Stanford |
ZIP/Postal code |
94305 |
Country |
USA |
|
|
Platform ID |
GPL13497 |
Series (2) |
GSE54187 |
Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features [transcriptome] |
GSE54188 |
Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features |
|